Filing Flows › Comparisons › AUPH vs SNDX
Aurinia Pharmaceuticals vs Syndax Pharmaceuticals: AUPH and SNDX compared
Aurinia Pharmaceuticals is the larger company: $83.7M of revenue in its latest quarter (Q3 2026) against $83.3M for Syndax Pharmaceuticals (Q3 2026). Syndax Pharmaceuticals is growing faster (+82% against +14% a year earlier). Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against -50.3%.
Where the money goes: AUPH and SNDX
Aurinia Pharmaceuticals (AUPH) · Q3 2026
Aurinia Pharmaceuticals, Q3 2026: revenue $83.7M (+14% year over year), operating margin 42.3%, net earnings $31.7M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
Syndax Pharmaceuticals (SNDX) · Q3 2026
Syndax Pharmaceuticals, Q3 2026: revenue $83.3M (+82% year over year), operating margin -50.3%, net loss $49.4M, operating cash flow −$27.3M. The chart follows the revenue to costs, profit and cash.
| Aurinia Pharmaceuticals (AUPH) | Syndax Pharmaceuticals (SNDX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $83.7M | $83.3M |
| Revenue growth, Y/Y | +14% | +82% |
| Operating margin | 42.3% | -50.3% |
| Net earnings | $31.7M | −$49.4M |
| Net margin | 37.9% | -59.3% |
| Operating cash flow | $46.4M | −$27.3M |
| Market value | $2.2B | $1.3B |
| P/E | 7.2× | — |
| Analysts’ mean target | $18.29 | $35.45 |
Where the revenue comes from
Aurinia Pharmaceuticals
- Net product sales: $79.4M (95%)
- License, collaboration and royalty revenue: $4.3M (5%)
Syndax Pharmaceuticals
- Product: $60.7M (73%)
- Collaboration Revenue: $22.6M (27%)
Questions
Which is bigger, Aurinia Pharmaceuticals or Syndax Pharmaceuticals?
Aurinia Pharmaceuticals is the larger company: $83.7M of revenue in its latest quarter (Q3 2026) against $83.3M for Syndax Pharmaceuticals (Q3 2026).
Is Aurinia Pharmaceuticals or Syndax Pharmaceuticals growing faster?
Syndax Pharmaceuticals is growing faster (+82% against +14% a year earlier).
Which is more profitable, Aurinia Pharmaceuticals or Syndax Pharmaceuticals?
Aurinia Pharmaceuticals is more profitable, with an operating margin of 42.3% against -50.3%.
More: Aurinia Pharmaceuticals earnings · how Aurinia Pharmaceuticals makes money · Syndax Pharmaceuticals earnings · how Syndax Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 30, 2026; 10-Q filed Nov 2, 2026). Fiscal quarters can end on different dates. Not investment advice.